Verity Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,282
| Closed | -$490K | – | 184 |
|
|
2020
Q3 | $490K | Buy |
4,282
+1,020
| +31% | +$117K | 0.37% | 69 |
|
|
2020
Q2 | $366K | Sell |
3,262
-284
| -8% | -$31.9K | 0.34% | 73 |
|
|
2020
Q1 | $318K | Sell |
3,546
-210
| -6% | -$18.8K | 0.4% | 82 |
|
|
2019
Q4 | $406K | Buy |
3,756
+24
| +0.6% | +$2.59K | 0.4% | 81 |
|
|
2019
Q3 | $366K | Buy |
3,732
+890
| +31% | +$87.3K | 0.38% | 84 |
|
|
2019
Q2 | $372K | Buy |
2,842
+112
| +4% | +$14.7K | 0.42% | 81 |
|
|
2019
Q1 | $369K | Sell |
2,730
-356
| -12% | -$48.1K | 0.43% | 70 |
|
|
2018
Q4 | $300K | Buy |
3,086
+131
| +4% | +$12.7K | 0.4% | 69 |
|
|
2018
Q3 | $411K | Buy |
2,955
+435
| +17% | +$60.5K | 0.41% | 59 |
|
|
2018
Q2 | $313K | Buy |
+2,520
| New | +$313K | 0.28% | 74 |
|
|
2018
Q1 | – | Sell |
-2,626
| Closed | -$313K | – | 151 |
|
|
2017
Q4 | $313K | Buy |
2,626
+454
| +21% | +$54.1K | 0.24% | 77 |
|
|
2017
Q3 | $260K | Sell |
2,172
-736
| -25% | -$88.1K | 0.2% | 92 |
|
|
2017
Q2 | $354K | Buy |
2,908
+482
| +20% | +$58.7K | 0.27% | 62 |
|
|
2017
Q1 | $294K | Buy |
+2,426
| New | +$294K | 0.24% | 76 |
|